CORONA Remedies Limited has informed the Exchange regarding 'Intimation under Regulation 30(5)'.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Corona Remedies Limited has submitted an intimation to the Exchange under Regulation 30(5) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. This provision requires listed companies to disclose details of their Key Managerial Personnel (KMPs) or other officials who are authorized to determine the materiality of events/information and to make timely disclosures to the stock exchange. While the specific names of authorized officials are not provided in the headline, this filing typically identifies officers such as the Managing Director, CEO, CFO, and Compliance Officer for this purpose. This is generally a routine governance-related disclosure required soon after listing or upon any change in authorized personnel.
This is a standard procedural disclosure and is not expected to materially impact the stock price or shareholder value. It reflects compliance with SEBI's disclosure norms, ensuring that the company has formally designated officials responsible for reporting material events to the exchange in a timely manner.